THE HAGUE, The Netherlands, September 3 /PRNewswire/ --     AEGON (LSE: AGN; NYSE: AEG) announced today that, in line with the share 
repurchase program announced on August 9, 2007, the company has repurchased 
5,050,000 common shares during the week of August 27 until August 31, 2007.

The common shares were repurchased at an average price of EUR 13.1870 for
a total amount of EUR 66,594,569.

The total number of common shares repurchased under this program to date
is 13,620,000 shares for a total consideration of EUR 178,776,283. To date
approximately 17.9% of the repurchase program has been completed.

For details on the repurchase program, see http://www.aegon.com.

ABOUT AEGON

AEGON is one of the world's largest life insurance and pension companies,
and a strong provider of investment products. AEGON empowers local business
units to identify and provide products and services that meet the evolving
needs of customers, using distribution channels best suited to local markets.
AEGON takes pride in balancing a local approach with the power of an
expanding global operation.

With headquarters in The Hague, the Netherlands, AEGON companies employ
approximately 30,000 people worldwide. AEGON's businesses serve millions of
customers in over twenty markets throughout the Americas, Europe, and Asia,
with major operations in the United States, the Netherlands and the United
Kingdom.

Respect, quality, transparency and trust constitute AEGON's core values
as the company continually strives to meet the expectations of customers,
shareholders, employees and business partners. AEGON is driven to deliver new
thinking with the ambition to be the best in the industry.

Forward looking statements

The statements contained in this press release that are not historical
facts may be forward-looking statements as defined in the U.S. Private
Securities Litigation Reform Act of 1995. Words such as 'believe',
'estimate', 'target', 'intend', 'may', 'expect', 'anticipate', 'predict',
'project', 'counting on', 'plan', 'continue', 'want', 'forecast', 'should',
'would', 'is confident' and 'will' and similar expressions as they relate to
us are intended to identify such forward-looking statements. These statements
are not guarantees of future performance and involve risks, uncertainties and
assumptions that are difficult to predict. We undertake no obligation to
publicly update or revise any forward-looking statements. Readers are
cautioned not to place undue reliance on these forward-looking statements,
which speak only as of their dates. All forward-looking statements are
subject to various risks and uncertainties that could cause actual results to
differ materially from expectations, including, but not limited to, the
following:

- Changes in general economic conditions, particularly in the United
States, the Netherlands and the United Kingdom;

- Changes in the performance of financial markets, including emerging
markets, including:

- The frequency and severity of defaults by issuers in our fixed income
investment portfolios; and

- The effects of corporate bankruptcies and/or accounting restatements on
the financial markets and the resulting decline in value of equity and debt
securities we hold;

- The frequency and severity of insured loss events;

- Changes affecting mortality, morbidity and other factors that may
affect the profitability of our insurance products;

- Changes affecting interest rate levels and continuing low interest rate
levels and rapidly changing interest rate levels;

- Changes affecting currency exchange rates, including the EUR/USD and
EUR/GBP exchange rates;

- Increasing levels of competition in the United States, the Netherlands,
the United Kingdom and emerging markets;

- Changes in laws and regulations, particularly those affecting our
operations, the products we sell and the attractiveness of certain products
to our consumers;

- Regulatory changes relating to the insurance industry in the
jurisdictions in which we operate;

- Acts of God, acts of terrorism, acts of war and pandemics;

- Changes in the policies of central banks and/or governments;

- Litigation or regulatory action that could require us to pay
significant damages or change the way we do business;

- Customer responsiveness to both new products and distribution channels;

- Competitive, legal, regulatory, or tax changes that affect the
distribution cost of or demand for our products;

- Our failure to achieve anticipated levels of earnings or operational
efficiencies as well as other cost saving initiatives;

- The impact on our reported financial results and financial condition as
a result of our adoption of International Financial Reporting Standards.

Contact Information

    Group Corporate Affairs & Investor Relations

    The Hague, the Netherlands
    Analysts & Investors : +31-(0)70-344-83-05
    Media: +31-(0)70-344-83-44
    E-mail: gca-ir@aegon.com

    Baltimore, the United States
    Analysts & 
    Investors: 877-548-9668 (toll free - USA only)/ +1-410-576-45-77
    E-mail: ir@aegonusa.com
    Website: http://www.aegon.com